Triple-negative Breast Cancer (TNBC): Neoadjuvant Benefits of Tecentriq® increases the pCR-Rate

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The outcome of special histologic types of triple-negative breast cancer (TNBC).
    Pogoda, Katarzyna
    Niwinska, Anna
    Murawska, Magdalena
    Olszewski, Wojciech
    Nowecki, Zbigniew
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Meeting the educational needs of women with triple-negative breast cancer (TNBC).
    Swiger, Kathleen Dickerson
    Sendecki, Jocelyn A.
    Guglielmino, Janine E.
    Rugo, Hope S.
    Domchek, Susan M.
    Anders, Carey K.
    Stricker, Carrie Tompkins
    Nelson, Hillary C. M.
    Hanson, Arin Ahlum
    Dinerman, Hayley
    Henry, Catherine Creme
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [24] Discovery of a small molecule inhibitor for triple-negative breast cancer (TNBC)
    Saran, Uttara
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Singh, Amandeep
    Ankem, Murali K.
    Sharma, Arun K.
    Damodaran, Chendil
    CANCER RESEARCH, 2022, 82 (12)
  • [25] Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review
    Tajbakhsh, Amir
    Rivandi, Mandi
    Abedini, Soheila
    Pasdar, Alireza
    Sahebkar, Amirhossein
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 140 : 17 - 27
  • [26] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [27] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [28] Inducing cell state transitions in triple-negative breast cancer (TNBC).
    Loo, Ser Yue
    Toh, Liping
    Pathak, Elina
    Tan, Wilson
    Ma, Siming
    Yuan, Ju
    Periyasamy, Giridharan
    Torta, Federico
    Chan, Jack
    Tan, Tira
    Sim, Yi Rong
    Tan, Veronique
    Tan, Benita
    Madhukumar, Preetha
    Yong, Wei Sean
    Ong, Kong Wee
    Wong, Chow Yin
    Wenk, Markus R.
    Foo, Roger
    Yap, Yoon-Sim
    Lim, Elaine
    Tam, Wai Leong
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 73 - 73
  • [29] Efficacy of neoadjuvant carboplatin/docetaxel chemotherapy in sporadic and BRCA-associated triple-negative breast cancer (TNBC)
    Sharma, Priyanka
    Stecklein, Shane R.
    Kimler, Bruce F.
    Khan, Qamar J.
    Connor, Carol Sue
    McGinness, Marilee
    Mammen, Joshua
    Wagner, Jamie Lynn
    Jensen, Roy A.
    Godwin, Andrew K.
    Fabian, Carol J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Spatial mapping of the immune microenvironment in primary triple-negative breast cancer (TNBC) and association with neoadjuvant therapy response
    Telli, M. L.
    Vinayak, S.
    Khododoust, M. S.
    Gruber, J. J.
    Ford, J. M.
    Sanchez, P.
    Banayan, N.
    Azimi, S.
    Tumeh, P. C.
    Newman, A. M.
    Alizadeh, A. A.
    CANCER RESEARCH, 2019, 79 (04)
12345